Your browser doesn't support javascript.
loading
A defect in myoblast fusion underlies Carey-Fineman-Ziter syndrome.
Di Gioia, Silvio Alessandro; Connors, Samantha; Matsunami, Norisada; Cannavino, Jessica; Rose, Matthew F; Gilette, Nicole M; Artoni, Pietro; de Macena Sobreira, Nara Lygia; Chan, Wai-Man; Webb, Bryn D; Robson, Caroline D; Cheng, Long; Van Ryzin, Carol; Ramirez-Martinez, Andres; Mohassel, Payam; Leppert, Mark; Scholand, Mary Beth; Grunseich, Christopher; Ferreira, Carlos R; Hartman, Tyler; Hayes, Ian M; Morgan, Tim; Markie, David M; Fagiolini, Michela; Swift, Amy; Chines, Peter S; Speck-Martins, Carlos E; Collins, Francis S; Jabs, Ethylin Wang; Bönnemann, Carsten G; Olson, Eric N; Carey, John C; Robertson, Stephen P; Manoli, Irini; Engle, Elizabeth C.
Afiliação
  • Di Gioia SA; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Connors S; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Matsunami N; Department of Neurology, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Cannavino J; Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.
  • Rose MF; Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA.
  • Gilette NM; Department of Molecular Biology and Neuroscience, and Hamon Center for Regenerative Science and Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 USA.
  • Artoni P; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • de Macena Sobreira NL; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Chan WM; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Webb BD; Medical Genetics Training Program, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Robson CD; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Cheng L; Broad Institute of M.I.T. and Harvard, Cambridge, Massachusetts 02142, USA.
  • Van Ryzin C; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Ramirez-Martinez A; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Mohassel P; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Leppert M; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Scholand MB; Department of Neurology, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Grunseich C; McKusick-Nathans Institute of Genetic Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
  • Ferreira CR; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Hartman T; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Hayes IM; Department of Neurology, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Morgan T; Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA.
  • Markie DM; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York 10029, USA.
  • Fagiolini M; Department of Radiology, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Swift A; Department of Radiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Chines PS; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Speck-Martins CE; F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Collins FS; Department of Neurology, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Jabs EW; Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892-1477, USA.
  • Bönnemann CG; Department of Molecular Biology and Neuroscience, and Hamon Center for Regenerative Science and Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 USA.
  • Olson EN; Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1477, USA.
  • Carey JC; Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA.
  • Robertson SP; Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA.
  • Manoli I; Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1477, USA.
  • Engle EC; Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892-1477, USA.
Nat Commun ; 8: 16077, 2017 07 06.
Article em En | MEDLINE | ID: mdl-28681861
ABSTRACT
Multinucleate cellular syncytial formation is a hallmark of skeletal muscle differentiation. Myomaker, encoded by Mymk (Tmem8c), is a well-conserved plasma membrane protein required for myoblast fusion to form multinucleated myotubes in mouse, chick, and zebrafish. Here, we report that autosomal recessive mutations in MYMK (OMIM 615345) cause Carey-Fineman-Ziter syndrome in humans (CFZS; OMIM 254940) by reducing but not eliminating MYMK function. We characterize MYMK-CFZS as a congenital myopathy with marked facial weakness and additional clinical and pathologic features that distinguish it from other congenital neuromuscular syndromes. We show that a heterologous cell fusion assay in vitro and allelic complementation experiments in mymk knockdown and mymkinsT/insT zebrafish in vivo can differentiate between MYMK wild type, hypomorphic and null alleles. Collectively, these data establish that MYMK activity is necessary for normal muscle development and maintenance in humans, and expand the spectrum of congenital myopathies to include cell-cell fusion deficits.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Pierre Robin / Músculo Esquelético / Síndrome de Möbius / Proteínas de Peixe-Zebra / Mioblastos / Proteínas de Membrana / Morfogênese / Proteínas Musculares / Doenças Musculares / Mutação Limite: Adult / Animals / Child / Female / Humans / Infant / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Pierre Robin / Músculo Esquelético / Síndrome de Möbius / Proteínas de Peixe-Zebra / Mioblastos / Proteínas de Membrana / Morfogênese / Proteínas Musculares / Doenças Musculares / Mutação Limite: Adult / Animals / Child / Female / Humans / Infant / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos